Clinical Trials Browser

OTHER × Glioma × spartalizumab × Clear all

NCT04943848 2026-03-17

rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG

Phase 1 Recruiting

Diffuse Intrinsic Pontine Glioma, Glioma